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PURPOSE: Previous studies have shown that metabolic syndrome z-score (MetSynZ) is 
improved with exercise training. Metabolic syndrome is based upon insulin resistance, such that 
it would be expected for insulin resistance to improve with exercise training. Currently, it is 
unknown if improvements in MetSynZ from exercise training are associated with improvements 
in systemic inflammation. The purpose of the present study is to evaluate the effect of exercise 
training on MetSynZ in participants with elevated C- reactive protein (CRP), and determine if 
changes in MetSynZ with exercise training were associated with changes in CRP and HOMA-IR 
(Homeostatic Model Assessment- Insulin Resistance). METHODS: The study sample included 
123 participants with elevated CRP levels from the Inflammation and Exercise (INFLAME) 
study. The participants were randomized into a control group and an exercise group. MetSynZ 
was defined as the sum of the z-scores from the NCEP-ATP III criteria. MetSynZ, CRP, and 
HOMA-IR were evaluated at baseline and follow up. The intervention consisted of aerobic 
exercise training for 4 months where total energy expenditure was approximately 16 
kilocalories/week per kilogram of body weight. RESULTS: Baseline CRP showed small, non-
significant, associations with MetSynZ. Analysis of covariance showed no significant change in 
MetSynZ between the exercise (-0.3, CI: -0.7 to 0.2) and control groups (0.2, CI: -0.2 to 0.6). 
Change in MetSynZ was not associated with change in CRP (r=-0.15, p=0.914), but was 
 
 
associated with change in the homeostatic model assessment of insulin resistance (HOMA-IR) 
(r=0.286, p=0.036). DISCUSSION: Results from the present study suggest that 4 months of 
aerobic exercise training may not be a sufficient time to favorably change MetSynZ. Reductions 
in MetSynZ with exercise training were not associated with improvements in systemic 
inflammation, but were associated with significant improvement in insulin resistance.  
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Chapter I: Introduction 
 The increased prevalence of insulin resistance, cardiovascular disease, and type 2 
diabetes are all major public health concerns that are growing in the United States [1]. The 
National Cholesterol Education Program- Adult Treatment Panel III (NCEP-ATP III) has 
defined a clustering of 3 or more risk factors (elevated blood pressure, elevated waist 
circumference, impaired fasting glucose, and dyslipidemia) known as the metabolic syndrome 
(MetSyn)[1, 2]. MetSyn is centered around insulin resistance, such that it increases overall risk 
for cardiovascular disease and type 2 diabetes [2-6]. Current estimates suggest that 22.9% of 
adults in the United States have the MetSyn [7]. Increasing physical activity and exercise 
training are potential strategies to reduce the prevalence of MetSyn and the severity of the 
aforementioned risk factors. An inverse relationship has been observed between high physical 
activity levels and cardiorespiratory fitness with MetSyn prevalence. Several exercise training 
studies have observed a reduction in MetSyn prevalence following intervention [8-15].  
 Much of the current scientific literature has described the MetSyn using categorical 
MetSyn definitions (NCEP [2], WHO [16], IDF definitions [17]); however, a limitation of this 
approach is that it may not thoroughly account for continuous changes in individual MetSyn risk 
factors. For example, if systolic blood pressure decreases from 140 to 132 mmHg, this would 
still be identified as a MetSyn risk factor (based on categorical definitions) despite the fact that a 
clinically significant reduction in blood pressure was achieved. Thus, the categorical definition is 
dependent on the presence or absence of 3 MetSyn risk factors [18]. Recently, researchers have 
utilized MetSyn z-score which uses a continuous risk score assessment scale [18]. Researchers 
have proposed that the categorical definition of MetSyn may not recognize these improvements 
in individual risk factors following exercise interventions because the reduction is not below the 
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cut off values for a risk factor [9]. MetSyn z-score uses a continuous risk score which may better 
identify improvements in individual risk factors despite reductions below recommended values.  
 Similar to the presence of MetSyn risk factors, an elevated level of C- reactive protein 
(CRP) is associated with an increased risk of cardiovascular events and other disease processes 
as it is represented by chronic elevated systemic inflammation [19-21]. Several studies suggest 
that a positive association exists between CRP level and the prevalence of MetSyn [19, 21-23]. 
Current data indicates that aerobic exercise training has been established as an effective 
treatment to reduce MetSyn z-score [8-15]. Recent data have shown that reductions in CRP with 
exercise training are associated with weight reduction [24]. It is possible that a reduction in waist 
circumference, a MetSyn risk factor, may be related to a reduction in weight and fat loss, which 
is a potential mechanism that may link the association between improvements in MetSyn z-score 
and CRP reduction following exercise training. This relationship may be of importance because 
of the pro-inflammatory pathway, as represented by elevated CRP, which is associated with the 
progression of multiple disease processes including increased cardiovascular disease risk and 
type 2 diabetes risk. However, to our knowledge, the effect of exercise training on changes in 
MetSyn Z-score and CRP has not been previously assessed in the literature.  
The purpose of the present study was to investigate the effect of aerobic exercise training 
on MetSyn z-score. Secondly, we evaluated whether reductions in MetSyn z-score were 
associated with reductions of CRP levels as a result of aerobic exercise training. The analysis of 
the study utilized data from the Inflammation and exercise (INFLAME) study which evaluated 
the effect of 4 months of aerobic exercise training on inflammatory markers in adults with 
elevated CRP at baseline. We hypothesize that aerobic exercise training will result in reduction 
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in MetSyn z-score, and that the reductions in MetSyn z-score following exercise training will be 
correlated with reductions in CRP levels.  
Limitations 
Limitations of this study design include not accounting for changes in medication 
throughout the intervention, the four month intervention duration, only using one exercise 
intensity during the exercise intervention, measuring the waist circumference at the umbilicus 
rather than the minimum waist, and z-scores were tabulated from the study population such that 
it can only be generalized for adults with elevated CRP levels.  
Delimitations 
Delimitations include not currently taking medication with confounding effects on 
inflammation, no current tobacco use in the past 6 months, randomized controlled design study, 
controlled and supervised exercise doses, and closely monitored energy expenditure.  
Key Terms 
Metabolic syndrome, metabolic syndrome z-score, C- reactive protein. 
Metabolic syndrome (MetSyn): a clustering of risk factors (elevated blood pressure, elevated 
waist circumference, impaired fasting glucose, and dyslipidemia) that increases the overall risk 
for insulin resistance, cardiovascular disease, and type 2 diabetes [6]. NCEP-ATP III guidelines 
define MetSyn as having three of the five following risk factors: waist circumference > 102 cm 
in men and 88 cm in women; triglycerides ≥ 150 mg/dL; High Density Lipoprotein (HDL) 
cholesterol < 40 mg/dL in men and 50 mg/dL in women; blood pressure ≥ 130 mmHG for 
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systolic blood pressure and/or 85 mmHg for diastolic blood pressure; and impaired fasting 
glucose ≥ 110 mg/dL [1, 2].  
Metabolic syndrome z-score: a statistically normalized z-score using means and standard 
deviations of the individual components of MetSyn that are then combined for a continuous risk 
score [9].  
C- reactive protein (CRP): a biomarker of systemic inflammation measured in the blood [22]. 
The National Institute of Health classifies CRP as low, average, and high risk with values <1.0 
mg/L, 1.0 to 3.0 mg/L, and >3.0 mg/L, respectively [25].  
Significance 
Although there are studies that have observed the relationship between MetSyn 
prevalence and CRP levels, limitations do exist. Few studies have evaluated the use of CRP 
levels as a predictor for having the MetSyn. It has been observed that exercise training has 
positive effects on both MetSyn z-score and CRP, independently. Despite this potential 
association between MetSyn and CRP, there are no studies to date that examine reductions in 
MetSyn z-score following an exercise intervention that are associated with reductions in 
inflammation. Determining a target pathway, such as inflammation, to improve cardiovascular 
risk as represented by MetSyn z-score could have important clinical relevance for developing 
exercise interventions. Since the relationship between MetSyn z-score and CRP has not been 
clearly defined, investigating the effects of exercise on this relationship may aid in the 
understanding of the potential mechanism of cardiovascular risk reduction.
Chapter II: Literature Review 
Metabolic Syndrome 
MetSyn is a constellation of risk factors (elevated blood pressure, elevated waist 
circumference, impaired fasting glucose, and dyslipidemia) that increases the overall risk for 
insulin resistance, cardiovascular disease, and type 2 diabetes [6]. Several health organizations 
(e.g. World Health Organization, International Diabetes Federation, and the National Cholesterol 
Education Program) have developed specific criteria and guidelines to identify individuals with 
the metabolic syndrome [2]. The National Cholesterol Education Program Adult Treatment Panel 
III (NCEP-ATP III) criteria are the most utilized among researchers and clinicians [1]. NCEP-
ATP III guidelines define MetSyn as having three of the five following risk factors: waist 
circumference > 102 cm in men and 88 cm in women; triglycerides ≥ 150 mg/dL; HDL 
cholesterol < 40 mg/dL in men and 50 mg/dL in women; blood pressure ≥ 130 mmHG for 
systolic blood pressure and/or 85 mmHg for diastolic blood pressure; and impaired fasting 
glucose ≥ 110 mg/dL[1]. Present research approximates that 22.9% of U.S. adults have MetSyn 
[7]. Cheal et al. [3] observed that the odds of insulin resistance increased 10-fold (odds ratio: 
10.7; 95% CI: 6.2,18.3) for those individuals who met the criteria for MetSyn compared to those 
without MetSyn. Adults with MetSyn have an increased significant relative risk for developing 
type 2 diabetes of 3.97 (95% CI:1.35,11.6) [5]. The relative risk of cardiovascular disease in 
presence of MetSyn is also increased at 2.96 (95% CI: 2.36,3.72) [26]. Thus, reducing the 
prevalence of MetSyn and its aforementioned risk factors has high clinical and public health 
importance. 
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Metabolic Syndrome z-score 
Recently, researchers have questioned whether the categorical definition of MetSyn is the 
best indicator of quantifying the overall risk associated with the MetSyn risk factors. The 
categorical method of defining MetSyn is dependent on the presence or absence of each risk 
factor. It has been suggested that the categorical definition of MetSyn may limit the evidence of 
improvement of individual risk factors for MetSyn as compared to a MetSyn z-score [9, 10]. For 
example, if a participant’s baseline blood pressure is 140/80 mmHg and reduces the value to 
132/80 mmHg following an exercise intervention, the categorical definition of MetSyn would 
not recognize the improvement as the recommended blood pressure value is below 130/85 
mmHg [1]. Consequently, the effects of exercise are attenuated as the components of MetSyn are 
viewed as a whole rather than individually [9].         
To determine continuous risk score for MetSyn, each risk factor’s individual z-score is 
computed from a standard deviation/sample mean of the sample. The z-scores for waist 
circumference, blood pressure, glucose, cholesterol, and triglycerides are then summed to 
represent the continuous risk for MetSyn [18]. Earnest et al. [9] proposes that defining MetSyn 
with the z-score accounts for intraindividual responses that differ within each component. 
When utilizing the categorical approach to determine MetSyn risk, exercise training 
could yield a reduction in certain risk factors which may not be below recommended values, 
such that the improvement is not recognized. MetSyn z-score recognizes improvement despite 
reductions below the threshold of recommended values. This in turn can benefit healthcare 
providers in defining the severity of an individual’s metabolic syndrome and risk for disease. 
Many studies have evaluated MetSyn through the categorical approach, but determining the 
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severity of the MetSyn in subjects through z-scores may translate more appropriately into the 
healthcare field when providers are creating a treatment plan.  
Effect of Aerobic Fitness Levels on Metabolic Syndrome  
It has been suggested that fitness level plays a role in MetSyn prevalence and MetSyn z-
score. Recent literature has observed that high cardiorespiratory fitness levels are inversely 
associated with MetSyn and MetSyn z-score [8, 9]. Farrell et al. [8] (N=7104) divided women 
into cardiorespiratory fitness quintiles according to age following a maximal treadmill test. 
MetSyn was identified by ATP III guidelines. Women in the highest fitness quintile had a 
significantly lower prevalence of MetSyn (2.7%) compared to those in the lowest fitness quintile 
(20.2%) [8]. Earnest et al. [9] also reported an inverse relationship between fitness level and 
MetSyn z-score for both sexes in a cross-sectional analysis of the Aerobics Center Longitudinal 
Study (N=38,659).  MetSyn z-score decreased across higher fitness levels for males (p<0.001) as 
well as for females (p<0.007) [9]. It is apparent from these data that cardiorespiratory fitness 
level is associated with MetSyn prevalence and MetSyn z-score. 
Metabolic Syndrome Prevalence Reduction with Aerobic Exercise Training 
Similar to the epidemiological research concerning fitness level, exercise training has 
been observed to reduce the prevalence of MetSyn [13, 14]. Tjǿnna et al. [14] randomly assigned 
32 participants with MetSyn to one of three groups: moderate continuous aerobic exercise, 
aerobic interval training, or control. Maximal aerobic capacity (VO2max), blood draws, and 
muscle biopsies were performed before and after the intervention which was designed to be 
performed three times per week for sixteen weeks. MetSyn was determined categorically 
according to World Health Organization criteria [14]. Aerobic interval training was significantly 
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associated with reduction in the number of risk factors for MetSyn from 6 to 4 (p<0.001). The 
continuous moderate exercise group produced favorable but non-significant changes from 6 to 5 
risk factors. Participants in the control group increased the number of risk factors from 5 to 6. It 
was observed that aerobic exercise training produced favorable improvements in MetSyn risk 
factors [14].  
 Katzmaryzk et al. [13] investigated the effect of an aerobic exercise training intervention 
on MetSyn prevalence using data from the HERITAGE family study. MetSyn was determined as 
3 or more risk factors as according to the NCEP-ATP III criteria. Participants with MetSyn 
present (N=105) performed 20 weeks of supervised aerobic exercise training which included 
three sessions per week using a cycle ergometer. The overall prevalence of MetSyn significantly 
decreased from 16.9% at baseline to 11.8% post training intervention (p<0.05). It appears that 
aerobic exercise training is an effective tool in reducing MetSyn prevalence.   
MetSyn z-score Reduction with Aerobic Exercise Training 
As current data suggests that exercise training aids in reduction of MetSyn prevalence, it 
has also been observed to aid in reduction of MetSyn z-score. It has been proposed that a dose-
response relationship exists between energy expenditure and MetSyn z-score reductions, such 
that moderate intensity aerobic exercise is sufficient in producing favorable changes [10, 11, 15]. 
Much of the present research on the effect of exercise training on MetSyn z-score is focused on 
special populations, such as women [10] and those with type 2 diabetes [11] that also have 
MetSyn. Earnest et al. [10] utilized data from the Dose-Response to Exercise in Women 
(DREW) aged 45 to 75 years study and observed that a cardiorespiratory exercise intervention 
for 6-months resulted in the reduction of MetSyn z-score in postmenopausal women (N=408). 
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Participants were randomly assigned to one of four groups: control, low intensity (4 kilocalories 
per kg per week or KKW), moderate intensity (8 KKW), or high intensity (12 KKW). The 
reduction in MetSyn z-score was significant only in the moderate and high intensity groups (-
3%, -9%, respectively). The control group had a 4% increase in MetSyn z-score. Those who 
expended more energy per week presented greater reductions in MetSyn z-score. Overall, the 
reductions in MetSyn z-score were positively associated with the total exercise energy 
expenditure.  
Similarly, Earnest et al. [11] observed a significant dose-response effect of 
cardiorespiratory exercise on MetSyn z-score in an ancillary analysis of the Health Benefits of 
Aerobic and Resistance Training in individuals with type 2 diabetes (HART-D) study (N=208). 
MetSyn was defined by NCEP-ATP III criteria and was determined by prevalence and z-score. 
Participants in the aerobic exercise training group expended ~12 KKW for 9-months by means of 
moderate to vigorous intensity on a treadmill. Participants in the non-exercise control group were 
asked to maintain their normal daily physical activity throughout the intervention; however, they 
were offered stretching and relaxing classes. The aerobic exercise training group had a baseline 
MetSyn z-score of 2.99±0.91 with a significant -0.5 reduction in MetSyn z-score following the 
intervention. The non-exercise control group had a baseline MetSyn z-score of 2.63±0.86 and a 
+0.03 increase in MetSyn z-score following the intervention. The authors observed that moderate 
intensity aerobic exercise was effective in reducing MetSyn z-score in those with type 2 diabetes 
[11].  
The Studies of a Targeted Risk Reduction Intervention through Defined Exercise 
(STRRIDE) evaluated the effects of 8 months of different volumes and intensities of exercise 
training. The differing volume and intensity exercise training groups included low 
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amount/moderate intensity, low amount/vigorous intensity, and high amount, vigorous intensity. 
Participants in the control group were asked to remain inactive and maintain their current dietary 
intake for 6 months. Johnson et al. [15] reported a significant improvement in MetSyn z-scores 
with low amounts of moderate intensity aerobic exercise (walking ~ 19 kilometers per week) 
compared to the control group (p<0.05). However, the change in MetSyn z-score was not 
different between the low amount/vigorous intensities group and control group. The authors also 
observed that the higher amount/vigorous intensity group improved MetSyn z-scores relative to 
the controls (p<0.0001), as well as the low amount/vigorous intensity group (p=0.001) and low 
amount/moderate intensity (p=0.007). This suggests that there is possibly a dose-response 
relationship [15]. It has been proposed that moderate intensities of aerobic exercise are sufficient 
reducing an individual’s MetSyn z-score.  
Summary: Metabolic Syndrome and Exercise Training 
Previous studies have observed that cardiorespiratory fitness level is inversely associated 
with MetSyn prevalence and z-score [8, 9]. Individuals can improve their MetSyn risk factors by 
improving their cardiorespiratory fitness through exercise training [8-15], which in turn reduces 
MetSyn prevalence and z-score. Current data suggests that moderate intensities may be sufficient 
to improve MetSyn in special and sedentary populations [11, 15]. This has important and 
practical implications for public health recommendations and messages. 
 
Metabolic Syndrome and C - reactive protein  
C- reactive protein (CRP) is measured to examine systemic inflammation, as 
inflammation is an inaugural step in multiple disease processes especially atherosclerosis [25]. 
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Evidence has recently emerged that CRP may be a strong predictor of MetSyn prevalence, 
cardiovascular disease and type 2 diabetes [21, 22]. According to the National Institute of 
Health, CRP levels are classified as low, average, and high risk with values < 1.0 mg/L, 1.0 to 3 
mg/L, and >3.0 mg/L, respectively [25]. It has been observed in few studies that individuals with 
multiple MetSyn risk factors tend to have higher CRP values compared to those with fewer 
MetSyn risk factors [19, 21-23]. Therefore, reductions in MetSyn z-score and reduction systemic 
inflammation may be associated.   
        Ridker et al. [22] (N=14,179) examined apparently healthy women who completed a follow 
up evaluation after an 8-year period for myocardial infarction, coronary revascularization, stroke, 
cardiovascular event death, and MetSyn. At baseline, 24.4% of the participants had MetSyn 
based on a categorical approach using NCEP ATP III criteria. Participants with no characteristics 
of the MetSyn had median CRP levels of 0.68 mg/L while those with 5 characteristics had 
median CRP levels of 5.75 mg/L. For those with 3 or more MetSyn characteristics CRP levels 
after the 8-year follow up were 3.38 mg/L, whereas those with no MetSyn characteristics CRP 
levels were 1.08 (p<0.0001).  
        Sattar et al. [23] evaluated baseline and follow-up assessments completed over a 4.9 year 
period of men from the West Scotland Coronary Prevention Study to determine the association 
between CRP and MetSyn. There was a 3.7 fold increase risk for coronary heart disease and 24.5 
fold increased risk for diabetes with the presence of 4-5 MetSyn risk factors when compared 
with those men who did not have 4-5 MetSyn risk factors. It was observed that CRP was higher 
at baseline (2.36±2.68 mg/L) in the 26% of men with MetSyn as compared to those without 
MetSyn (1.56±2.97 mg/L), (p<0.0001). Higher CRP levels with the presence of MetSyn 
predicted higher risk for cardiovascular disease (Hazard Ratio (HR): 2.75; 95% CI: 2.1, 3.6) and 
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diabetes (HR: 5.3; 95% CI: 3.3, 8.3). [23]. It appears that CRP is an appropriate addition to 
prediction methods for risk of cardiovascular disease, diabetes, and MetSyn.  
Effect of Exercise Training on C –reactive protein 
As fitness level and exercise training plays a role in MetSyn, it has also been observed to 
have an effect on CRP levels. Ford et al. [27] analyzed data from the National Health and 
Nutrition Examination Survey III (1988-1994) (N=13,748) to evaluate the relationship between 
physical activity and inflammation as represented by CRP. Elevated CRP levels were recorded in 
21% of participants that reported no physical activity, 17% that reported light physical activity, 
13% that reported moderate physical activity, and 8% that reported vigorous physical activity 
(p<0.001). It was proposed that there is an inverse relationship between physical activity and 
CRP levels [27].  
Numerous studies have evaluated the effect of exercise training on CRP levels in varying 
populations such as those with coronary heart disease, older adults, and adults with elevated CRP 
levels [18, 24, 28-30]. Goldhammer et al. [30] (N=28) observed reductions in CRP following a 
12-week aerobic exercise training program in participants with coronary heart disease. The 
exercise intensity was set at 70-80% of their individual maximal heart rate for 45 minute sessions 
3 times per week. Additionally, the participants attended 2 half hour calisthenics group exercise 
sessions per week. It was observed that exercise training induced favorable improvements in 
CRP levels by 48% from baseline (7.5±4.2 mg/L) to post training (3.9±3.5 mg/L) (p<0.01). 
These reductions were independent of changes in body weight [30]. Milani et al. [28] (N=35) 
examined the effect of exercise training on CRP through a three-month formal phase II cardiac 
rehabilitation program in patients with coronary heart disease. Exercise training produced 
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significant reductions from baseline (5.9±7.7 mg/l) to post exercise training (3.8±5.8 mg/l) 
(p<0.0001). These data suggest that exercise training elicits favorable improvements in CRP for 
participants with coronary heart disease [28, 30]. 
Recent data suggests that CRP reduction following exercise training is dependent on 
weight loss and fat reduction [18, 24, 29]. Vieira et al. [29] randomized 127 community residents 
ages 60-83 into a flexibility group (n=61) and a cardio group (n=66). The participants were 
sedentary for 6 months prior to the 10 month exercise intervention. The flexibility group 
participated in 2 supervised exercise sessions for 75 minutes per week during which they 
completed flexibility and balance exercises. The cardio group participated in 3 supervised 
cardiovascular exercise sessions for 45-60 minutes at 60-70% VO2max. A significant reduction 
in CRP following exercise was observed for the cardio group (-0.5 mg/L) (p=0.009). Reductions 
in CRP were also significantly correlated with reductions in both body fat percentage (r=0.193) 
and trunk fat mass (r=0.222) (p<0.05) [29].  
Few randomized controlled exercise training trials have observed that reductions in CRP 
were positively associated with reductions in weight [18, 24]. Stewart et al. [24] (N=421) 
concluded that a 6 month aerobic exercise training intervention yielded CRP reductions that were 
significantly and positively associated with weight (r=0.15; p<0.001) and waist circumference 
(r=0.12; p=0.01). Participants that expended 12 KKW lost 5.9 (±3.0) kg and had a reduction in 
CRP of 1.0 (±2.8) mg/L. Church et al. [18] utilized data from the Inflammation and Exercise 
(INFLAME) study to evaluate the effect of exercise training on CRP. It was observed that 
reduction in CRP was associated with weight loss (r=0.34) and change in body fat mass (r=0.35) 
following 4 months of aerobic exercise training reductions (p<0.01). It is reasonable that 
reductions in waist circumference and weight reduction may perhaps be related, such that this 
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may be the mechanism that explains the association between MetSyn z-score and CRP [18, 24, 
29]. 
Summary  
It is probable that there is an association between MetSyn z-score and CRP level 
following exercise training [22, 23]; however, there is currently no available research on this 
topic. Current research supports that CRP levels are associated with an increased risk for MetSyn 
[19, 21-23]. It has been established that aerobic exercise training has beneficial effects in 
reducing MetSyn z-score, as well as waist circumference [8-15]. Few studies have observed that 
exercise training yields favorable improvements in CRP level [18, 24, 28-30] . Weight loss, 
which may be represented by improvements in waist circumference, has been positively 
correlated with reduction in CRP levels following an aerobic exercise training intervention [18, 
24, 29] . This association between MetSyn z-score and CRP may exist due to the observation that 
exercise training aids in reduction of waist circumference, an individual risk factor of MetSyn, as 
well as weight reduction that yields CRP reductions. These exercise related reductions in MetSyn 
z-score could possibly mediate cardiovascular disease risk by reduction in inflammation. This 
potential association could hold important implications in the understanding of the mechanism 
for improvement in health risk with MetSyn z-score reduction.  
 
 
 
Chapter III: Methods 
 Participants 
                The present study was a secondary analysis of the Inflammation and Exercise 
(INFLAME) study (N=162). The main methodology and primary outcomes of INFLAME has 
been previously published [18, 31]. The INFLAME study was designed to determine the effect 
of exercise training on elevated CRP levels in sedentary men and women [31]. All participants 
provided a written informed consent prior to enrollment in the study and the INFLAME study 
was approved for analysis by the Institutional Review Board at the Cooper Institute. Participants 
in the INFLAME study were healthy, sedentary men and women between the ages of 30 and 75 
years old with elevated CRP levels (≥2.0 mg/L but <10 mg/L). Sedentary behavior was defined 
as exercising less than 20 minutes per day on less than 3 days per week. Other major inclusion 
criteria included body mass index (BMI) > 18.5 kg/m2 and < 40.0 kg/m2, fasting glucose < 126 
mg/dL, resting blood pressure < 140 mmHg systolic and/or 90 mmHg diastolic, no current 
tobacco use in the past 6 months, and not currently taking specific medications that had 
confounding effects on inflammation (statins, angiotensin converting enzyme inhibitors, oral 
contraceptives, multi-vitamins, aspirin, ibuprofen, and other anti-inflammatory medications). 
Major exclusion criteria included specific medications (hormone replacement therapy, beta 
blockers, allergy shot, or systemic corticosteroids), significant cardiovascular disease or 
disorders (serious arrhythmias, cardiomyopathy, congestive heart failure, stroke, peripheral 
vascular disease with intermittent claudication, acute, chronic, or recurrent thrombophlebitis, 
stage II or III hypertension, myocardial infarction, or an abnormal exercise stress test), total 
cholesterol ≥ 240 mg/dL with LDL-C ≥190 mg/dL or triglyceride levels > 300 mg/dL, and other 
significant medical conditions (chronic or recurrent respiratory, gastrointestinal, neuromuscular, 
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neurological, or psychiatric conditions, musculoskeletal problems interfering with exercise, or 
any other medical condition or disease that may be life-threatening, may interfere with, or be 
aggravated by exercise activities). Only participants with adherence levels above 75% were 
included in the analysis. Participants without data for all components for MetSyn data were 
excluded from the analysis.  
Outcome Measures 
Weight was measured to the nearest 0.1 kg using a calibrated electronic scale (Siemens 
Medical Solutions, Malvern, PA) with the participant wearing a hospital gown. Height was 
measured using a standard stadiometer. Body composition was measured via dual energy x-ray 
absorptiometry (DXA) using a Hologic Bone Densitometer (Hologic Inc., Bedford, MA). 
Abdominal circumference was determined by standard measuring techniques at the level of the 
umbilicus [32]. A 10-12 hour fasting blood sample was drawn to measure CRP and lipids. 
Fasting plasma glucose was measured by the hexokinase-glucose-6-phosphate dehydrogenase 
method. Insulin was measured using electrochemiluminescence. Blood pressure measurements 
were collected following a 20 minute supine rest period with a Colin STBP-780 automated BP 
unit (Colin Medical Instruments Corp., San Antonio, TX). Homeostasis Model Assessment- 
Insulin Resistance (HOMA-IR) was used to determine the insulin: glucose interaction using a 
computer model [33]. All assessment measures were performed at baseline and follow-up. The 
assessment staff was blinded from group randomization.  
C- reactive protein Analysis 
Prior to blood draws to determine CRP levels participants fasted for 10-12 hours, 
abstained from alcohol consumption and exercise for 24 hours, and refrained from acute usage of 
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aspirin or other anti-inflammatory medications for 48 hours. Those participants who reported use 
of anti-inflammatory medications at the orientation visit were asked to abstain from use of the 
medication prior to the blood draw.  
Blood was drawn baseline and follow-up, and then stored at -80° C. CRP assays were 
performed only after both baseline and follow-up samples are available such that the 
measurement was completed with the same assay kit. CRP was measured by a solid-phase, 
chemiluminescent immunometric assay (Immulite 2000, High-Sensitivity CRP, Diagnostic 
Products Corporation, Los Angeles, CA). 
Metabolic Syndrome z-score 
MetSyn z-score was computed by computing a z-score from the study population mean 
and standard deviation of each risk factor (waist circumference, fasting glucose, HDL, 
triglycerides, and mean arterial pressure). Mean arterial pressure was determined through the 
equation: MAP= diastolic blood pressure- 1/3 (systolic blood pressure-diastolic blood pressure). 
The individual z-scores were summed together to create a composite MetSyn z-score.   
Intervention 
Following baseline assessments participants were randomized to an exercise group or a 
control group. Individuals randomized into the exercise group participated in supervised aerobic 
exercise for four months. The total energy expenditure was set at 16 kcal/kg per week (KKW) 
which was divided into 3-5 sessions per week. A two-week ramping period was used to ease 
participants into the exercise intervention to minimize injury, soreness, and dropout. The first 
week began at 10 KKW and the second week at 12KKW. Exercise intensity was 60-80% of 
maximal oxygen consumption (VO2max) which was determined from their baseline exercise test. 
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Participants alternated modes of exercise between the treadmill and cycle ergometers to prevent 
injury occurrence. Heart rates, blood pressure, rate of perceived exertion, mode, and speed/grade 
or watts were recorded during each exercise session. The control group remained physically 
inactive throughout the duration of the intervention. Non-exercise physical activity during the 
intervention was measured through the use of step counters (Accusplit Eagle, Japan) in both 
groups. The exercise group was allowed up to 10 exercise sessions out of the laboratory and 
were provided with heart rate monitors and exercise prescriptions. Participants recorded the 
duration and intensity of the exercise to be included in their weekly energy expenditure. Dietary 
intake was tracked and participants were asked to not make any changes to their diet. No changes 
in diet or non-exercise physical activity were observed between the aerobic and control group. 
Statistical Analysis 
The primary outcomes of this analysis were the change in MetSyn z-score, as well as the 
association of changes in CRP following an aerobic exercise intervention. Baseline data was 
tabulated in means and standard deviations. Group differences in baseline data was evaluated 
with a t-test. Adherence was determined by dividing each participant’s actual energy expenditure 
by the study prescribed energy expenditure of 16 KKW. Change in MetSyn z-score was analyzed 
using an analysis of covariance (ANCOVA) between the control and exercise group. Covariates 
in the analysis were designated and included a priori baseline value of the respective variable and 
age. Change in CRP was analyzed using an ANCOVA. The covariate in this analysis was 
designated as a priori baseline value. Results are presented in adjusted least squared means with 
95% confidence intervals. Pearson correlations were utilized to evaluate the association between 
change in MetSyn z-score and change in CRP prior to and following exercise training. The 
association of HOMA-IR and MetSyn z-score was assessed in a post-hoc analysis by Pearson 
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correlation. Statistical significance for all statistics was defined as p<0.05. These analyses were 
completed with SPSS software (SPSS version 17.1, Chicago, 2009).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter IV: Results 
The control group population had a mean (SD) age of 50.9 (1.4) years, a mean BMI of 
32.0 (3.9) kg/m2, with 9.1 % African American and 66.7 % female. Baseline CRP was 4.5 (2.6) 
mg/L. The exercise group had a mean (SD) age of 50.6 (1.3) years, a mean BMI of 30.9 (4.4) 
kg/m2, with 10.5 % African American and 78.9 % female, and baseline CRP was 5.1 (4.2) mg/L. 
Significant differences between the groups existed at baseline for HDL, waist circumference, 
fasting glucose, plasma insulin, and HOMA-IR. Baseline characteristics for both control and 
exercise groups are summarized in Table 1. As described in Table 1, the control and exercise 
groups were significantly different at baseline for MetSyn z-score (p<0.004). There was a 
significant association between MetSyn z-score and CRP at baseline (r=0.193, p=0.34). There 
was a significant association at baseline for MetSyn z-score and HOMA-IR for both groups 
(r=0.561, p=0.000). 
Table 2 presents the change in z-score for each MetSyn component following the 
intervention for the control group and exercise group. There were no significant differences 
between the control and exercise groups for changes in z-score for triglycerides, fasting glucose, 
mean arterial pressure, or HDL-cholesterol (p>0.05). However, the change in waist 
circumference z-score was significantly different (control: 0.1 [.01, 0.3] versus exercise: -0.08 [-
0.2, 0.05], p< 0.022). The adjusted mean change in CRP was similar in the control and exercise 
groups with no significant difference between groups (control: 0.5 [-0.6, 1.5] versus exercise: 0.4 
[-0.7, 1.6], p=0.922). 
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As represented in Figure 1, there were small, non-significant differences observed in z-
score changes between the control and exercise group following the intervention (0.2 [CI: -0.2, 
0.6] versus -0.3 [CI:-0.7, 0.2], p=0.114).  
Figure 2 depicts the change in MetSyn z-score and change in CRP in the in exercise 
group only. Changes in MetSyn z-score were not significantly associated with change in CRP 
(r=-0.15, p=0.914).   
Figure 3.A. depicts the positive and significant association between MetSyn z-score 
change and change in HOMA-IR in the exercise group (r=0.286, p=0.036). Figure 3.B. depicts 
the significant association of change in MetSyn z-score and change in insulin in the exercise 
group (r=0.305, p=0.025). Figure 3.C. represents a significant association of change in MetSyn 
z-score and change in glucose in the exercise group (r=0.445, p=0.001).  
 
 
 
 
 
 
 
 
Chapter V: Discussion 
 The primary findings of the present study were that 4 months of aerobic exercise training 
resulted in no change in MetSyn z-score and no association was observed between MetSyn z-
score and systemic inflammation as measured by CRP. However, insulin resistance as assessed 
by HOMA-IR was positively and significantly associated with changes in MetSyn z-score 
following exercise training. These data suggest that a reduction in cardiovascular disease risk as 
represented by MetSyn z-score may not be mediated through a pro-inflammatory pathway but 
through improvements in insulin resistance. The present study is the first to our knowledge to 
examine the relationship between changes in MetSyn z-score with inflammation indicated by 
CRP following exercise training.  
 Categorical MetSyn determines the presence of elevated cardiovascular and type 2 
diabetes risk by identifying cut-off points. MetSyn z-score determines the presence and severity 
of that elevated risk through a continuous risk score. Utilization of MetSyn z-score by healthcare 
providers ensures that improvements in individual risk factors following exercise training can be 
identified even if they are not below the recommended values. As discussed in previous 
literature, exercise training has been shown to promote a reduction of MetSyn z-score based on 
data from several randomized controlled trials [10, 11, 15]. In contrast to these findings, we 
observed no change in MetSyn z-score following exercise training. This discrepancy in results 
may be due to differences in intervention duration and total energy expenditure during the 
exercise intervention. In the present study, participants exercised for 4 months while the 
interventions in previous studies lasted between 6-9 months [10, 11, 15]. Moreover, the 
accumulation of total energy expenditure of 16 KKW after 4 months in the present study may not 
have been enough to elicit a reduction in MetSyn z-score. Previous studies had varying energy 
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expenditures throughout their interventions (ranging from 8 to 23 KKW) in which greater energy 
expenditure accumulations were achieved compared to the present study [10, 11, 15]. It is 
feasible that the duration and total energy expenditure of the present study’s exercise 
intervention was not extensive enough to yield a significant reduction in MetSyn z-score and 
multiple components of MetSyn.  
No studies to date have examined the relationship between MetSyn z-score and 
inflammation following exercise training; however, epidemiological research has suggested that 
a greater number of risk factors for MetSyn is associated with elevated CRP [21-23]. 
Additionally, previous literature has observed that reductions in CRP are dependent upon weight 
and fat loss following exercise training ranging from 4-10 months in duration [18, 24, 29]. 
Although the results of the present study suggest that there were significant changes in waist 
circumference z-score following the exercise intervention, we did not observe an association 
between change in MetSyn z-score and CRP. As with change in total MetSyn z-score, the 4 
month duration and total energy expenditure may not have been extensive enough to elicit 
reductions in waist circumference of a necessary magnitude to demonstrate a relationship 
between MetSyn z-score and CRP. Although it is possible that the reduction in disease risk as 
represented by MetSyn z-score could be mediated through a pro-inflammatory pathway, this is 
not supported by the data in the present study. 
In the present analysis, the effects of aerobic exercise training on MetSyn z-score were 
driven by improvements in glucose control and insulin resistance as measured by HOMA-IR. 
Both glucose and insulin were positively and moderately associated with MetSyn z-score change 
following the exercise intervention. As glucose is a component of MetSyn and HOMA-IR, it was 
expected that it would be a probable link between MetSyn z-score and HOMA-IR. However, we 
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observed a positive association between change in insulin and change in MetSyn z-score. 
MetSyn was defined upon characteristics of insulin resistance such that risk factors for MetSyn 
are generally similar to those of insulin resistance [6]. Based upon that definition, it would be 
expected that insulin resistance measurements are associated with changes in MetSyn z-score. 
The present results suggest that small, incremental changes in MetSyn z-score may be beneficial 
to improvement in insulin resistance.   
The present study had several strengths. INFLAME was a randomized, controlled trial. 
The exercise dose during the intervention was controlled with extensive monitoring of energy 
expenditure during training sessions. The aerobic exercise program was consistent with public 
health recommendations. Exercise adherence levels were excellent (>90%) in the exercise group 
and we excluded participants with low adherence levels from the present analysis. Thus, the lack 
of significant findings for the primary analyses of the present study are not due to inadequate 
levels of exercise. Additionally, the inclusion/exclusion criteria of the present study were 
designed with intention to evaluate individuals with chronically elevated CRP while excluding 
individuals with acute inflammatory conditions. To control for confounding of medication on 
CRP, entry into the study was restricted by usage of anti-inflammatory medications and 
medications that may attenuate reductions in CRP. However, the study also had several 
limitations. The results cannot be generalized to other populations such as adults with normal 
CRP levels (as the study population included adults with elevated CRP). Additionally, the 
MetSyn z-score was determined using the study population compared to using population based 
data. The intervention was limited to only aerobic exercise training and did not investigate the 
effect of other exercise modalities such as resistance or circuit training. Lastly, the intervention 
duration for INFLAME was only four months and it is plausible that a more extended exercise 
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intervention and greater accumulation of total energy expenditure may have resulted in more 
favorable changes in MetSyn z-score.  
Conclusion 
The results of the present study suggest that reductions in MetSyn z-score following 4 
months of aerobic exercise training are not mediated through an inflammatory pathway, but 
rather through improvements in insulin resistance for individuals with elevated CRP. MetSyn z-
score is a valuable tool that can be used by healthcare and exercise professionals to evaluate the 
change in cardiovascular disease risk and type 2 diabetes risk to develop exercise interventions to 
target improvement in insulin resistance. Future studies should investigate if a relationship 
between MetSyn z-score and systemic inflammation are observed following a longer aerobic 
exercise training intervention, following different training modalities, or using more sensitive 
measures of insulin resistance. 
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Tables and Figures 
Table 1. Baseline characteristics for the Control and Exercise Groups. Results presented as 
Mean (SD). * represents significance between groups, p<0.05. 
  Control 
 (n=66) 
Exercise 
 (n=57) 
Age (years) 50.9 (1.4) 50.6 (1.3) 
BMI (kg/m
2
) 32.0 (3.9) 30.9 (4.4) 
Ethnicity 
African American (%), n 
(9.1%), 6.0 (10.5%), 6.0 
Sex 
Female (%), n 
(66.7%), 44.0 (78.9%), 45.0 
High Density Lipoprotein (mg/dL) 51.7 (11.7) 58.1 (15.4)* 
Triglycerides (mg/dL) 117.0 (42.0) 110.0 (46.3) 
Mean Arterial Pressure (mmHg) 97.8 (12.0) 95.7 (12.8) 
Waist Circumference (cm) 100.2 (12.5) 95.7 (12.6)* 
Fasting Glucose (mg/dL) 97.0 (10.2) 93.0 (9.7)* 
Plasma Insulin (pmol/L) 84.7 (41.4) 68.2(34.2)* 
VO2 (L/min) 1.61 (0.7) 1.60 (0.7) 
C-reactive Protein (mg/L) 4.5 (2.6) 5.1 (4.2) 
HOMA-IR 3.4 (1.9) 2.7(1.5)* 
MetSyn z-score  0.7 (2.9) -0.9 (3.0)* 
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Table 2. Change in z-score for each MetSyn component and CRP. Results presented as Mean 
(95% Confidence Interval). Each component was adjusted for baseline z-score. * represents 
significance between groups, p<0.05.  
MetSyn component, z-score Control Exercise p-value 
High Density Lipoprotein  0.02 (-0.1, 0.2) -0.08 (-0.2, 0.07) 0.325 
Triglycerides -0.06 (-0.2, 0.1) -0.04 (-0.2, 0.1) 0.868 
Mean Arterial Pressure 0.08 (-0.1, 0.3) -0.1 (-0.3, 0.1) 0.193 
Waist Circumference 0.1 (.01, 0.3) -0.08 (-0.2, 0.05) 0.022* 
Fasting Glucose 0.07 (-0.1, 0.3) -0.1 (-0.4, 0.06) 0.136 
C- reactive protein 0.5 (-0.5, 1.5) 0.4 (-0.7, 1.5) 0.922 
 
Figure 1. Change in MetSyn z-score for Control and Exercise group. Z-scores adjusted for 
baseline z-score and age. The data represents the least-squares means and 95% confidence 
intervals. (0.2 [CI: -0.2, 0.6] versus -0.3 [CI:-0.7, 0.2], p=0.114). 
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Figure 2. Change in MetSyn z-score and CRP for Exercise Group. (r=-0.15, p=0.914). 
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Figure 3.A. Change in MetSyn z-score and HOMA-IR for Exercise Group (r=0.286, p=-.036). 
3.B. Change in MetSyn z-score and Insulin for Exercise Group (r=0.305, p=0.025). 3.C. Change 
in MetSyn z-score and Glucose for Exercise Group (r=0.445, p=0.001). 
A) 
B)  
   C)  
     
